“Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies”, J of Skin, vol. 5, no. 6, p. s51, Nov. 2021, doi: 10.25251/skin.5.supp.51.